Berberine in Cardiovascular and Metabolic Health
Abstract
Berberine is a highly versatile botanical with extensive physiological activity resulting from its ability to interact with numerous enzyme systems, receptor sites, and cell signaling pathways. Both pre-clinical and clinical studies continue to shed light on berberine's therapeutic potential, corroborating many of its traditional uses. Berberine has antioxidant and anti-inflammatory effects and can help regulate certain metabolic processes. For example, studies show that berberine may improve insulin resistance, support insulin secretion, inhibit lipogenesis, and rebalance the gut microbiome. The roster of novel molecular targets that berberine influences continues to be discovered, with its ability to regulate adenosine monophosphate (AMP) levels and induce AMP-activated protein kinase (AMPK) being chief among them. AMPK activity, which declines with age, is crucial for the proper functioning of cellular metabolism.
Read the paper
Related studies
- Bile Acid 7α-Dehydroxylating Gut Bacteria Secrete Antibiotics that Inhibit Clostridium difficile: Role of Secondary Bile Acids
- Ketogenic diet alleviates colitis by reduction of colonic group 3 innate lymphoid cells through altering gut microbiome
- Altered gut microbiome composition and function are associated with gut barrier dysfunction in healthy relatives of patients with Crohn's disease
- Diet, obesity, and the gut microbiome as determinants modulating metabolic outcomes in a non-human primate model
- Immune Impairment Associated with Vitamin A Deficiency: Insights from Clinical Studies and Animal Model Research
- Glyphosate-based herbicides influence antioxidants, reproductive hormones and gut microbiome but not reproduction: A long-term experiment in an avian model
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.